Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

translational research

This page shows the latest translational research news and features for those working in and with pharma, biotech and healthcare.

CRUK forges £30m ‘post-Brexit’ R&D alliance

CRUK forges £30m ‘post-Brexit’ R&D alliance

funding towards translational research projects in cancer and particularly immuno-oncology. ... No single organisation or country is going to beat cancer on its own, ”commented Dr Iain Foulkes, executive director of research and innovation at CRUK.

Latest news

  • Christina Coughlin to leave Immunocore for Tmunity Christina Coughlin to leave Immunocore for Tmunity

    Tmunity’s determination to go it alone shows its ambition, and the team now calls itself “a new centre of gravity”in translational T cell medicine. ... In addition to her great immunotherapeutic industry knowledge, Chris will also fuse the research

  • Evotec says Sanofi deal makes it anti-infectives powerhouse Evotec says Sanofi deal makes it anti-infectives powerhouse

    That essentially means getting other research groups to put drug candidates through Evotec’s R&D platform, and tapping into public funding sources. ... regulatory approvals of course – and that will give it “the highest qualified translational

  • Ferring agrees Chinese reproductive medicine research deal Ferring agrees Chinese reproductive medicine research deal

    Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) are set to collaborate on a long-term project to advance basic and translational research in reproductive medicine. ... Professor Hongemi Wang, director of the state key laboratory, CAS,

  • Novartis and Bayer among backers for European big data project Novartis and Bayer among backers for European big data project

    A European project to advance big data-driven cardiovascular research has launched with EU and pharma backing. ... To do this the IMI consortium will develop a data-driven translational research platform to deliver clinically relevant disease phenotypes,

  • ICON boosts leadership teams ICON boosts leadership teams

    He has over 30 years of experience in pharmaceutical and contract research organisation (CRO) roles, joining from Quintiles where he led its global clinical analysis and reporting services group. ... Most recently, Dr McCracken led the Imaging Centre of

More from news
Approximately 5 fully matching, plus 64 partially matching documents found.

Latest Intelligence

  • The real-world data conundrum The real-world data conundrum

    Studies (including a review from my team in 2016 published in BMC Health Services Research) now show that evidence from real-world data is increasingly used to inform published guidelines and ... To address expectations and capitalise on the value of real

  • The reality of real-world evidence The reality of real-world evidence

    The rise of health technology assessment (HTA) globally puts significant emphasis on health economic and outcome research (HEOR) analysis and RWE provides critical inputs into this. ... To meet this demand organisations need to work together to enable or

  • Real-world evidence Real-world evidence

    An emerging solution is the use of routinely collected data or clinical databases, research outputs of which are often collectively called real-world evidence (RWE). ... To fully capitalise on the potential value of using RWE, researchers need to ensure

  • EATRIS and the new age of partnering EATRIS and the new age of partnering

    It gained elite European Research Infrastructure Consortium status from the European Union in 2013 and has just staged its second annual conference - Building Bridges in Translational Medicine - where international speakers hailed ... we reduce the

  • The rise of chronic disease in BRIC markets The rise of chronic disease in BRIC markets

    Prior to that in September 2012, Novo Nordisk invested $100m in expanding its diabetes research facilities in Beijing. ... a translational science centre specialising in cancer research.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

  • Adjusting to change in healthcare: Learning from translational research

    Translational research organisations are responding by adjusting their strategies to align with the NHS, to contribute to delivering better patient outcomes, faster. ... Traditionally, the role of translational research is to increase the volume of basic

  • Blue Latitude Health

    Adjusting to change in healthcare: Learning from translational research. ... In this article, Blue Latitude Health's Head of Insight, Martine Leroy, explores how pharma could learn from translational research organisations in adapting their approach to

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Quick links

Infographics

Multimedia